In the last 150 years, ophthalmic pathology as a defined discipline has taken shape thanks to the organized efforts of both ophthalmologists and pathologists. Ophthalmic pathology has steadily contributed to the advancement of the understanding of ocular diseases and the origin, behavior, prognosis, and treatment of ocular and periocular tumors. The practice of ophthalmic pathology has undergone changes mandated mostly by external circumstances and also by the advancement of science and technology.1,2 In the early stages of the specialty, pioneers in the field like Dr James Wardrop were clinicians who had a special interest that took them beyond the clinical presentation into the pathologic processes of disease. Dr Wardrop studied the pathology of retinoblastoma in the late 18th and early 19th centuries in the United Kingdom.1,2 Frederick Verhoeff and Jonas Friedenwald were notable pioneers of the eye pathology field in the first half of the 20th century. In the second half of the 20th century, there were both ophthalmologists and pathologists who worked full time in ophthalmic pathology and contributed to most of the knowledge we currently have for the discipline. In America, Professor Lorenz E. Zimmerman of the Armed Forces Institute of Pathology, Washington, DC, trained many great ophthalmic pathologists, some of whom are currently practicing. In Europe, Professor Norman Ashton from London, England, also trained many in the field. All helped shaped what we now know as the basis of ophthalmic pathology by describing their findings, publishing peer-reviewed manuscripts and books, and most importantly sharing their knowledge and experience with many physicians interested in ocular pathology and the study of tumors of the eye.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Ophthalmology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.